Before you read this
This information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely.
If you have concerns about vitamin levels, supplements, or symptoms, please speak with your NET clinical team. They can assess your individual situation and guide you safely.
What this Spotlight covers
A boundary‑focused, NET‑relevant overview of zinc: its physiological role, why deficiency is common in NET patients, how it presents, and what patients should understand when discussing zinc status with their clinical team.
1. What Zinc Does
Zinc is an essential trace mineral involved in:
- Enzyme function (over 300 enzymes)
- Immune regulation
- Skin integrity and wound healing
- Taste and smell
- DNA synthesis and cell repair
Zinc is absorbed mainly in the small intestine, especially the duodenum and proximal jejunum, via specialized transporters that regulate uptake based on the body’s needs.
2. Why Zinc Deficiency Occurs in NET Patients
Impact of Surgery on Zinc Absorption
- Surgery involving the duodenum can impair zinc absorption since the duodenum is a primary site for zinc uptake.
- Resection or damage to the duodenum reduces the surface area and transport capacity for zinc absorption.
- Pancreatic surgery affecting enzyme and bicarbonate secretion can further disrupt zinc absorption and balance.
- These surgical impacts increase the risk of zinc deficiency in NET patients.
Chronic diarrhoea
- Zinc is lost in stool due to increased intestinal secretion and reduced absorption.
- High-output diarrhoea increases daily zinc losses significantly because rapid transit time reduces zinc absorption and damaged intestinal lining allows more zinc to leak into stool.
- Pancreatic secretions containing zinc are also reduced or lost, further impacting zinc balance.
Surgery‑related malabsorption
- Resection of small bowel segments reduces zinc absorption.
- Faster transit time decreases uptake.
Somatostatin analogue therapy
- SSAs reduce pancreatic secretions, which can impair absorption of several micronutrients including zinc.
Reduced dietary intake
- Patients with nausea, early satiety, or restrictive diets may consume less zinc.
Zinc deficiency is not as universal as iron or vitamin D issues, but it is relevant in NET patients with diarrhoea, malabsorption, or prior bowel surgery.
3. Symptoms of Zinc Deficiency
Symptoms can be subtle and easily mistaken for treatment effects or general cancer‑related changes.
Common symptoms include:
- Altered taste (dysgeusia)
- Reduced appetite
- Hair thinning
- Skin rashes or slow wound healing
- Increased susceptibility to infections
- Diarrhoea (can be both a cause and a consequence)
4. How Zinc Status Is Assessed
Zinc is difficult to measure accurately because most zinc is inside cells.
Tests may include:
- Serum zinc (most common, but influenced by inflammation and other factors)
- Plasma zinc (alternative)
- Clinical assessment (symptoms + risk factors)
Serum and plasma zinc testing methods such as atomic absorption spectrometry (AAS), inductively coupled plasma optical emission spectrometry (ICP-OES), and inductively coupled plasma mass spectrometry (ICP-MS) show good accuracy and precision when standardized, but results can vary between laboratories due to calibration differences.
Factors like systemic inflammation, specimen collection time, fasting status, and sample processing can affect zinc levels, making interpretation challenging.
Therefore, zinc testing should be combined with clinical context for best assessment.
Zinc is difficult to measure accurately because most zinc is inside cells.
Tests may include:
- Serum zinc (most common, but influenced by inflammation)
- Plasma zinc (alternative)
- Clinical assessment (symptoms + risk factors)
Inflammation can lower serum zinc even when total body stores are adequate.
5. Treatment Options
Dietary sources
- Meat, poultry, seafood (especially oysters)
- Dairy products
- Nuts, seeds, legumes
Oral zinc supplements
- Zinc sulfate, gluconate, or acetate
- Best taken away from iron or calcium supplements (they compete for absorption)
Monitoring
- Long‑term high‑dose zinc can cause copper deficiency, so balanced supplementation is important. See other risks of excess Zinc below.
6. Special Considerations in NETs
- Patients with chronic diarrhoea are at highest risk.
- Post‑surgical patients may require periodic monitoring.
- Taste changes can worsen nutritional intake, creating a feedback loop.
- Zinc deficiency may contribute to diarrhoea, compounding losses.
7. When to Discuss Zinc With Your Clinical Team
Patients should consider raising zinc status if they experience:
- Persistent taste changes
- Unexplained skin issues
- Hair thinning
- Frequent infections
- Chronic diarrhoea
- History of small bowel surgery
8. Risks of Excess Zinc
While zinc is essential, too much zinc can be harmful. Excessive zinc intake may cause:
- Nausea, vomiting, and diarrhea
- Headaches and stomach pain
- Reduced absorption of copper, potentially leading to copper deficiency
- Impaired immune function
- Anemia and nerve damage with chronic high doses
The recommended upper limit for zinc intake in adults is generally 40 mg per day. Chronic intake above this level, especially doses of 100-150 mg/day or more, can interfere with copper metabolism and cause adverse effects. Acute exposure to zinc fumes (e.g., in industrial settings) can cause metal fume fever, a temporary illness with fever, muscle aches, and respiratory symptoms.
Patients taking zinc supplements should follow clinical guidance to avoid excessive dosing and monitor for side effects.
(References: Merck Manual, Medical News Today)
9. Key Takeaways
- Zinc is essential for immune function, taste, and skin health.
- Deficiency is reasonably common in NET patients with diarrhoea or bowel surgery (including the duodenum).
- Symptoms are often subtle and easily overlooked.
- Supplementation is effective but should be monitored to avoid copper deficiency.
- Clinical studies report zinc deficiency prevalence around 30% in GEP-NET patients, rising to over 50% in those with steatorrhoea, somatostatin analogue therapy, or prior bowel surgery (including duodenal involvement).
- Despite this, zinc testing is not yet routine in many NET clinics, contributing to underdiagnosis.
- ENETS guidelines emphasize vitamins ADEK and B12 due to stronger evidence and clinical familiarity.
- Emerging research and recent ENETS position statements advocate for broader nutritional screening including zinc, especially in patients with diarrhoea, malabsorption, or bowel surgery.
- Increased awareness and further research are needed to integrate zinc testing into routine NET patient care.
- Zinc plays critical roles in cellular metabolism, immune response, oxidative stress regulation, and tumor biology.
- Dysregulation of zinc homeostasis and zinc transporter expression is linked to cancer development and progression, supporting the biological plausibility of zinc deficiency impacting NET patients.
10. Resources
- NHS
- NIH
- Clement DS, Tesselaar ME, van Leerdam ME, Srirajaskanthan R, Ramage JK. Nutritional and vitamin status in patients with neuroendocrine neoplasms. World J Gastroenterol. 2019 Mar 14;25(10):1171-1184. doi: 10.3748/wjg.v25.i10.1171. PMID: 30886501; PMCID: PMC6421241.
- P1 Clinical risk factors for micronutrient deficiencies in patients with gastroenteropancreatic neuroendocrine tumours: a real-world evaluation Wattagodage Ananda, Jennifer Blackhouse, Rajeev Sasikumar & Mohid Khan.
- Hall, A.G., King, J.C. & McDonald, C.M. Comparison of Serum, Plasma, and Liver Zinc Measurements by AAS, ICP-OES, and ICP-MS in Diverse Laboratory Settings. Biol Trace Elem Res 200, 2606–2613 (2022). https://doi.org/10.1007/s12011-021-02883-z
Thanks for reading
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Jimmy Buffett 1946-2023 – Neuroendocrine Carcinoma (Merkel Cell Carcinoma)September 3, 2023Awareness
The Syndromes of Neuroendocrine Cancer – Early Signs of a Late DiagnosisJune 14, 2024A spotlight on NENs – Syndromes
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient AdvocacyDiscover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.







